A new therapeutic strategy for electrical cardioversion of atrial fibrillation

Italian Heart Journal

Volumn 2, Issue 11, 2001, Pages 831-840

  De Luca, I ^a   Sorino, M ^a   Del Salvatore, B ^a   De Luca, L ^a  

^a POLICLINICO   (Italy)

Author keywords

Atrial fibrillation; Electrical cardioversion; Low molecular weight heparins; Transesophageal echocardiography

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTERY THROMBOSIS; ARTICLE; CARDIOVERSION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DOSE TIME EFFECT RELATION; FEMALE; FOLLOW UP; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEPARINIZATION; HOSPITALIZATION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PROFESSIONAL STANDARD; SINUS RHYTHM; STUNNED HEART MUSCLE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CLINICAL PROTOCOLS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; ENOXAPARIN; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0035674262     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Echocardiographic predictors of non rheumatic atrial fibrillation: The Framingham Heart Study
2. Epidemiology and natural history of atrial fibrillation: Clinical implications
3. Electrical reversion of cardiac arrhythmias
4. Immediate and long-term results of electrical cardioversion of arrhythmias
5. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation
6. Anticoagulation for cardioversion of atrial fibrillation
7. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
8. Antithrombotic therapy in atrial fibrillation
9. The ACUTE pilot study: A randomized, controlled trial
10. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: A prospective, intraoperative study
11. Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?
12. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study
13. Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography
14. Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous echo contrast characterization by simultaneous transesophageal echocardiography
15. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thrombo-embolic complications
16. Utilizzo dell'ecocardiografia transesofagea e delle eparine a basso peso molecolare nella cardioversione elettrica della fibrillazione atriale
17. Pilot study on the use of postcardioversion transoesophageal echocardiography
18. Low-molecular-weight heparins
19. Low-molecular-weight heparin during instability in coronary artery disease
20. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)
21. Long-term low-molecular-mass heparin in unstable coronary artery disease: FRISC II prospective randomized multicentre study
22. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
23. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
24. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: From the investigators of Consensus on Diastolic Dysfunction by Echocardiography
25. Assessment of left atrial appendage structure and function by transesophageal echocardiography
26. Lo stunning atriale postcardioversione: Cosa è importante conoscere?
27. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study
28. Cardioversion from atrial fibrillation without prolonged anticoagulation with the use of transesophageal echocardiography to exclude the presence of atrial thrombi
29. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
30. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
31. Impaired left atrial mechanical function after cardioversion: Relationship to the duration of atrial fibrillation
32. Return of atrial function postcardioversion: Comparison between left atrial appendage and left atrial cavity function by Doppler transesophageal echocardiography
33. Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion
34. Evaluation of left atrial appendage function by measurement of changes in flow velocity patterns after electrical cardioversion in patients with isolated atrial fibrillation
35. Assessment of left atrial appendage function after cardioversion of atrial fibrillation: Relation to left atrial mechanical function
36. Left atrial chamber and appendage function after internal atrial defibrillation: A prospective and serial transesophageal echocardiographic study
37. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: A retrospective analysis
38. Linee guida e pratica clinica: Terapia anticoagulante e cardioversione della fibrillazione atriale
39. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation
40. Cardioversion in atrial fibrillation. Results and complications in 1152 prospective patients